GANZETTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 5.281
EU - Europa 2.711
AS - Asia 1.970
SA - Sud America 487
Continente sconosciuto - Info sul continente non disponibili 157
AF - Africa 143
OC - Oceania 7
Totale 10.756
Nazione #
US - Stati Uniti d'America 5.121
SG - Singapore 531
IT - Italia 530
VN - Vietnam 427
UA - Ucraina 414
BR - Brasile 400
RU - Federazione Russa 376
CN - Cina 367
DE - Germania 249
FR - Francia 242
IE - Irlanda 217
SE - Svezia 215
TR - Turchia 167
DK - Danimarca 141
FI - Finlandia 126
HK - Hong Kong 117
GB - Regno Unito 104
KR - Corea 80
CI - Costa d'Avorio 78
BD - Bangladesh 76
IN - India 74
CA - Canada 62
MX - Messico 38
AR - Argentina 34
ZA - Sudafrica 23
IQ - Iraq 19
JP - Giappone 19
PL - Polonia 18
ES - Italia 16
NL - Olanda 16
CO - Colombia 14
ID - Indonesia 14
MA - Marocco 14
JM - Giamaica 12
EC - Ecuador 11
CW - ???statistics.table.value.countryCode.CW??? 10
PK - Pakistan 10
UZ - Uzbekistan 10
RO - Romania 9
KZ - Kazakistan 8
AU - Australia 7
CH - Svizzera 7
GT - Guatemala 7
LT - Lituania 7
MY - Malesia 7
PY - Paraguay 7
SV - El Salvador 7
TT - Trinidad e Tobago 7
VE - Venezuela 7
CL - Cile 6
CR - Costa Rica 6
DZ - Algeria 6
HN - Honduras 6
IL - Israele 6
EU - Europa 5
KE - Kenya 5
PH - Filippine 5
PR - Porto Rico 5
HR - Croazia 4
NP - Nepal 4
PE - Perù 4
TH - Thailandia 4
AT - Austria 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
NI - Nicaragua 3
PT - Portogallo 3
SA - Arabia Saudita 3
SN - Senegal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
EG - Egitto 2
GP - Guadalupe 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
OM - Oman 2
SC - Seychelles 2
SM - San Marino 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LY - Libia 1
Totale 10.608
Città #
Ashburn 810
Jacksonville 402
Chandler 378
Fairfield 315
Singapore 300
Dallas 295
Council Bluffs 244
Dublin 216
Boardman 192
San Jose 153
New York 146
Wilmington 146
Ho Chi Minh City 135
Woodbridge 134
Houston 128
Hong Kong 117
Seattle 109
Beijing 95
Cambridge 94
Hanoi 94
Los Angeles 90
San Mateo 86
Princeton 83
Lawrence 82
Abidjan 78
The Dalles 78
Centro 74
Lauterbourg 69
Munich 60
Milan 57
São Paulo 54
Ann Arbor 50
Moscow 49
Hefei 43
Buffalo 37
Turku 35
Turin 33
Rome 32
London 31
San Diego 31
Orem 29
Da Nang 28
Haiphong 26
Pune 25
Santa Clara 21
Des Moines 20
Porto 19
Guangzhou 18
Helsinki 18
Montreal 18
Shanghai 18
Marche 16
Phoenix 16
Chicago 15
Atlanta 14
Johannesburg 14
Rio de Janeiro 13
Warsaw 13
Miano 12
Norwalk 12
Chennai 11
Toronto 11
Boston 10
Brooklyn 10
Denver 10
Naples 10
Tokyo 10
Willemstad 10
Wuhan 10
Kilburn 9
Poplar 9
Ancona 8
Manchester 8
Mexico City 8
Tashkent 8
Baghdad 7
Belo Horizonte 7
Charlotte 7
Frankfurt am Main 7
Istanbul 7
Jiaxing 7
Kingston 7
Kolkata 7
Thái Bình 7
Washington 7
Amsterdam 6
Bologna 6
Cagliari 6
Civitanova Marche 6
Guarulhos 6
Jinhua 6
Madrid 6
Salvador 6
San Francisco 6
San Salvador 6
Almaty 5
Bauru 5
Biên Hòa 5
Bogotá 5
Bắc Giang 5
Totale 6.317
Nome #
Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature 232
Active inflammatory biomarkers in oral lichen planus 220
Adipochine e citochine proinfiammatorie nella psoriasi: ruolo modulante di Etanercpet 208
A patient with psoriasis and vitiligo treated with etanercept 186
Adalimumab modulates angiogenesis in psoriatic skin 181
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 173
A non-responsive chronic autoimmune urticaria in a 12-year-old autistic girl treated with cyclosporin. 171
Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis 171
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 171
T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: At the origin of the problem 168
Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial 167
Tossicità cutanea da inibitori dell’Epidermal Growth Factor Receptor (EGFR): valutazione clinico-istologica ed approccio terapeutico 166
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 163
Homocysteine plasma levels in psoriasis patients: our experience and review of the literature 162
TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in Cutaneous Mesenchymal Stem Cells of psoriasis patients. 160
Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases 157
Biologic Therapy in Psoriasis: Safety Profile 156
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 155
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 154
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial 153
Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. 151
The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. 151
Dermoscopic features of conjunctival melanocytic lesions 150
Certolizumab pegol for the treatment of psoriasis 149
CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept. 147
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 147
Response to letter to the editor: 'a precise knowledge of ozonated oils will help to define the favourable and peculiar properties of these functional dermatological matrices' 144
Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel 141
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region 140
Skin features in myotonic dystrophy type 1: An observational study 139
Alopecia Areata: a possible extraintestinal manifestation of Crohn's disease. 139
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 139
Purely cutaneous Langerhans' cell histiocytosis in an adult woman 138
Primary cutaneous large cell lymphoma CD30+: a case-based review 136
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines 136
Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. 135
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 133
Relapsing acute generalized exanthematous pustolosis: a guess. 133
Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives 133
Factitious disorders in adults: two cases of unusual skin ulcers 132
The successful off-label use of photodynamic therapy for classic Porokeratosis of Mibelli:case report" 131
Doxycycline-Isoniazid: a new therapeutic association for recalcitrant acne agminata 131
The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients 128
Microvessel density and VEGF, HIF-1α expression in primary oral melanoma: correlation with prognosis 126
The switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group 124
Effect of Allium Cepa-Allantoin-Pentaglycan Gel on Skin Hypertrophic Scars: Clinical and Video-Capillaroscopic Results of an Open-Label, Controlled, Nonrandomized Clinical Trial. 123
Use of infliximab in toxic epidermal necrolysis: a still opened challenge 123
Lesional skin chemokine CTAK/CCL27 expression in mycosis fungoides and disease control by IFN-A and PUVA therapy. 120
Mycosis Fungoides-like Eruption and Infliximab 120
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 120
Hidradenoma papilliferum: diagnostic challenge 119
Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy. 118
Lifelong widespread warts associated with human papillomavirus type 70/85: a new diagnostic entity? 118
Insulin resistance, serum insulin and HOMA-R 114
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes. 114
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 113
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 113
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 112
Cutaneous CCL27 expression in early-stage mycosis fungoides: its role in the balance between the tumoral infiltrate and anti-tumoral immune response, and prognostic utility as a predictor of recurrence. 111
The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis. 111
Hemangioma in POEMS syndrome:an atypical clinical and histological presentation 108
Treatment of focal idiopathic hyperhidrosis with botulinum toxin type-A: clinical predictive factors of relapse free survival 104
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 103
Normolipemic plane xanthomatosis with acute development preceding the clinical onset of rheumatoid arthritis 100
Rosacea: could topical azelaic acid and oral tetracyclines modify videocapillaroscopic pattern? 100
Osteopontin: a new facilitating factor in alopecia areata pathogenesis? 99
Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: Results of a retrospective analysis 99
Non-alcoholic fatty liver disease and psoriasis: So far, so near 98
La qualità della vita nel paziente psoriasico: esperienza di due anni del centro Psocare della Clinica Dermatologica di Ancona. 97
Possibile ruolo delle molecole di adesione nei meccanismi patogenetici delle lesioni bollose nei pemfigoidi 97
Reciprocal altered expression of E-Cadherin in mucous membrane pemphigoid. 97
VEGF, survivin and NOS overexpression in psoriatic skin: Critical role of nitric oxide synthases 97
Videocapillaroscopic pattern of Alopecia Areata before and after diphenylciclopropenone treatment. 97
Phototherapy in Dermatology 95
In vitro activity of the lipopetide derivative (Pal-lys-lysNh2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes 93
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background 92
Possibile ruolo delle molecole di adesione cellula-cellula nei meccanismi patogenetici del pemfigo volgare 91
SERUM LEVELS OF TH1 AND TH2 CHEMOKINES IN CUTANEOUS T CELL LYMPHOMAS (CTCL) 88
Metabolic Features in Psoriasis 86
Topical ozonated oil versus hyaluronic gel for the treatment of partial- to full-thickness second-degree burns: A prospective, comparative, single-blind, non-randomised, controlled clinical trial. 86
Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo 79
Inflammatory bowel diseases and the skin: a monography 74
Totale 10.756
Categoria #
all - tutte 51.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022363 0 0 0 0 4 31 31 44 32 47 63 111
2022/20231.124 103 142 103 82 78 124 1 77 295 6 85 28
2023/2024707 119 17 51 91 109 165 15 23 2 17 7 91
2024/20251.203 181 104 30 14 57 20 103 28 269 77 149 171
2025/20263.450 256 258 277 401 376 239 537 289 253 259 120 185
2026/2027947 236 120 141 380 70 0 0 0 0 0 0 0
Totale 10.756